Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Gross Block

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Gross Block History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Gross Block ₹5,910 Cr₹5,233 Cr₹4,247 Cr₹2,160 Cr₹1,988 Cr

What is the latest Gross Block ratio of MANKIND PHARMA ?

The latest Gross Block ratio of MANKIND PHARMA is ₹5,910 Cr based on Mar2024 Consolidated results.
Year Gross Block
Mar2024₹5,910 Cr
Mar2023₹5,233 Cr
Mar2022₹4,247 Cr
Mar2021₹2,160 Cr
Mar2020₹1,988 Cr

How is Gross Block of MANKIND PHARMA Trending?

Years Gross Block % Change
Mar2024 ₹5,910 Cr
12.93
Mar2023 ₹5,233 Cr
23.23
Mar2022 ₹4,247 Cr
96.60
Mar2021 ₹2,160 Cr
8.67
Mar2020 ₹1,988 Cr -

Compare Gross Block of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,240.6 Cr -2.1% -0.6% 33.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,352.0 Cr 1.7% -4.7% 48.8% Stock Analytics
DIVIS LABORATORIES ₹159,265.0 Cr 4.4% 3.1% 66% Stock Analytics
CIPLA ₹120,035.0 Cr -0.9% -1.7% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,286.0 Cr -1% -8.9% 6.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,461.4 Cr -1% -4% 48.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.1%

-0.6%

33.1%

SENSEX

1.8%

-2.5%

19.9%


You may also like the below Video Courses